A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

• Autores principales: Michael D. Schultz (Autor), John J. Suschak (Autor), Davide Botta (Autor), Aaron Silva-Sanchez (Autor), R. Glenn King (Autor), Thomas W. Detchemendy (Autor), Chetan D. Meshram (Autor), Jeremy B. Foote (Autor), Fen Zhou (Autor), Jennifer L. Tipper (Autor), Jianfeng Zhang (Autor), Kevin S. Harrod (Autor), Sixto M. Leal (Autor), Troy D. Randall (Autor), M. Scot Roberts (Autor), Bertrand Georges (Autor), Frances E. Lund (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The coronavirus disease 2019 (COVID-19) pandemic has illustrated the critical need for effective prophylactic vaccination to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Intranasal vaccination is an attractive approach for preventing COVID-19 as the nasal mucos...